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ibstract The fission yeast Schizosaccharomyces pombe has 
proven useful for studying molecular interactions between a range 
*)f signal transduction components. We now report the first co- 
expression of a mammalian seven-transmembrane receptor and 
G-protein components in S. pombe. We selected the human neu- 
rokinin NK2 receptor together with its G-protein-signalling part- 
oer G, for this study. Yeast membrane fractions showed high 
levels of NK2 receptor-binding activity (1159 f 534 (n = 3) fmoll 
mg protein) although initial experiments with intact cells revealed 
m absence of receptors at the cell surface. Using a construct 
comprising the NK2 coding sequence fused with the signal se- 
quence from an endogenous phosphatase (phol), we detected -400 
VK2 receptors/cell in unbroken yeast. Successful co-expression 
i,f the NK2 receptor with the G-protein subunits G,, /H or p2 
dnd y3 failed to modulate agonist binding, suggesting the absence 
i)f functional interaction between these components. As an alter- 
native test of G, function, we next expressed its downstream 
effector target phospholipase C-p1 (PLCpl) in S. pombe. Al- 
rhough PLCpl undergoes powerful in vitro activation by G, 
derived from baculovirus-infected Sf9 cells and mammalian cells, 
6, expressed in S. pombe is totally ineffective. Similar results 
were also achieved with the G-protein subunit G,,,. Together, 
Fhese data suggest that seven-transmembrane receptors can be 
tsxpressed in S. pombe at high levels and directed to the cell 
surface although their interaction with co-expressed G-proteins 
In undetectable. Production of inactive G,-chains in S. pombe 
may account for these observations. 
Key words: Schizosaccharomyces pombe; NK2 neurokinin 
.eceptor; G-protein; G,; PLCBI; Heterologous expression 
1. Introduction 
The seven-transmembrane superfamily of receptors mediate 
&verse cellular actions through interaction with heterotrimeric 
s-proteins and subsequent regulation of a range of down- 
stream effector and second messenger systems [ 1,2]. One impor- 
ant second messenger response triggered by many G-protein- 
inked receptors is phospholipase C (PLC)-dependent hydroly- 
,is of membrane phosphatidylinositol 4,5-bisphosphate (PIP,) 
o generate the second messengers inositol 1,4,5_trisphosphate 
IP,) and diacylglycerol (DAG) [3,4]. More than 20 distinct 
;-protein a-chains are currently identified and members of the 
3, class play an critical role mediating increased PIP, hydroly- 
is following activation of PLCP isoforms [2,5-71. 
One important approach for demonstrating basic mecha- 
lisms for G-protein-dependent PIP, breakdown has involved 
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heterologous expression of selected components in tranformed 
cell lines [8-111. Unfortunately, a high background of en- 
dogenous regulatory elements in mammalian cells complicates 
interpretation of the precise and specific molecular interactions 
under study. For instance, although a single G-protein-linked 
receptor can couple to multiple effector and second messenger 
systems [12-l 71, it is often unclear whether these responses are 
direct or secondary to second messenger generation or kinase 
activation. An alternative approach is to express selected signal 
transduction components in a cellular enviroment with a lim- 
ited complement of endogenous G-protein-linked receptors or 
associated signalling elements. One such system is the fission 
yeast Schizosaccharomyces pombe in which only two seven- 
trdnsmembrane mating factor receptors and two endogenous 
G-protein a-chains have been identified [ 18-211. The budding 
yeast Saccharomyces cerevisiae also expresses only a limited 
complement of G-protein components [ 1,221 and has been used 
as a host to express the human /?2-adrenergic receptor together 
with the G-protein a-chain G,, [23]. Hitherto, no such studies 
have been reported using yeast for G-protein-linked receptors 
mediating PIP? hydrolysis. 
The fission yeast S. pombe has emerged as a new and adapt- 
able host cell system in which to study the function and molec- 
ular interactions of mammalian signal transduction compo- 
nents. So far, these have included PKC isoenzymes [24], Src and 
its negative regulator Csk [25,26], the PDGFb receptor and 
PLCy [26], Raf-1 and MAP kinase kinase [27] as well as Ras 
and the phosphatidylinositol3-kinase subunits ~8% and pl 1Oa 
[28]. The advantages of this yeast system are due in part to the 
availability of range of expression vectors based on the tightly 
regulatable and powerful promoter nmt [29]. In this paper, we 
describe the first report of a mammalian seven-transmembrane 
receptor co-expressed with G-protein components in S. pombe. 
As a reflection of our interest in G-protein-dependent PIPI 
hydrolysis, we selected the neurokinin NK2 receptor together 
with G, for these experiments. 
2. Experimental 
2.1. Strains, mediu and plasmid constructs 
The host strain for S. pombe transformation, growth media and the 
procedure for protoplast transformation were as described [26]. The 
human NK2 receptor cDNA was obtained from Dr. E. Kawashima 
(Glaxo Institute for Molecular Biology, Geneva, Switzerland) while 
cDNAs encoding mouse G,,, bovine Gal and human GgZ were provided 
by Professor M.I. Simon (California Institute ofTechnology. Pasadena, 
CA) and have been described previously [30-321. Bo&e G+ and 
PLQ’?l cDNAs were generous gifts from Dr. N. Gautam (Washington 
University, St Louis, MO) and Dr. P. Parker (Imperial Cancer Re- 
search Fund, London, UK), respectively, and were as reported [33,34]. 
Human G,,, was provided by Dr. C. Power (Glaxo Institute for Molec- 
ular Biology). For expression in fission yeast, coding sequences from 
the above cDNAs were excised using appropriate restriction enzymes, 
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or in some cases, amplified by PCR, and subcloned into the nmtl-based 
expression vectors [29] as follows: The NK2 receptor was subcloned 
into the pREPI (Leu’) vector; G, subunits were subcloned into the 
pREP4 (Urn’) vector; G,, and GB2 subunits were expressed from the 
pREP7 vector which contains the S. pomhe hi.& selectable marker (E. 
Leberer and K. Maundrell, unpubl. data): Gy3 was expressed from 
pREP5 which contains the ade6’ selectable marker; PLC/?l was ex- 
pressed from pREP3. With this series of constructs all three subunits 
of the heterotrimeric G-protein could be co-expressed with either its 
seven-transmembrane receptor or its downstream effector PLC/?l with 
each plasmid being maintained in the cell by independent selection. For 
COS cell expression, the genes for G,, and G,,, were amplified by PCR 
using primers which placed a consensus eukaryotic translation initia- 
tion sequence [36] at the 5’-end of the gene and cloned into pSG5 or 
pBKCMV (Stratagene). pSGS/G,,, pBKCMV/G,,, and the NK2 re- 
ceptor expression vector pCDL/NKZ were transfected in COS-7 cells 
by electroporation [17,35]. 
2.2. NK2 receptor binding 
For binding to intact yeast, l-3 x IO’ cells were harvested by centrif- 
ugation at 1000 x g for 5 min, washed in 40 ml of 0.9% (w/v) NaCl, and 
resuspended in buffer N (25 mM Tris, 100 mM NaCl, 0.2% (w/v) BSA, 
pH 7.4) containing 3 mM MnCl?. For binding to membrane fractions, 
yeast homogenates were prepared exactly as described [26] and diluted 
in buffer N. Saturation-binding experiments were performed by mixing 
aliquots of intact cells (24 x 10’ cells) or homogenates (50-100 pg 
protein) with the NK2 antagonist [3H]SR48968 (26 Ci/mmol; Amer- 
sham, Zurich, Switzerland) at the concentrations indicated in a total 
volume of 1 .O ml for 120 min at room temperature. Non-specific bind- 
ing was determined in parallel tubes using the NK2-selective antagonist 
CR94800 at 2 PM [37]. Competition binding was performed under 
identical conditions using 0.5-1.0 nM [jH]SR48968 and antagonists or 
agonists at the concentrations indicated. GTPyS was included at 100 
PM where indicated. Binding was terminated by rapid filtration 
through glass fibre filters (GF/B) presoaked with 10 mM Tris-HCI 
containing 0.5% (v/v) polyethylenimine (pH 7.4) followed by 3 washes 
of 4.0 ml with ice-cold buffer N containing 0.02% (w/v) BSA. 
2.3. Measuring PLCpl activity with exogenous substrate 
Crude homogenates of G,,-expressing baculovirus-infected Sf9 cells 
or transformed S. pombe were preactivated with GTPyS as described 
[38]. PLC/?l was expressed in S. pombe (see above) and activation by 
G,, was measured using [‘HIPIP as substrate [38]. Where COS cell 
membranes were used as a source of G,, or G,,,, membrane prepara- 
tion as well as G-protein and PLCpl activation were performed as 
described previously [8]. In these experiments, S. pombe membranes 
containing G,, or G,,, were prepared in parallel under identical condi- 
tions. 
2.4. Immunodetection qf’ G,,, G,,,, Gp,. G,,, rl und PLCgl 
Preparation of membrane fractions, sodium dodecyl sulphate (SDS)- 
polyacrylamide gel electrophoresis and Western blotting were per- 
formed as described [26] using 10.0% (PLC/31), 12% (G,,, G,,,, G8, and 
Gpz) or 20% gels (G,,)). Polyclonal antibodies detecting G,, were gen- 
erated in house using keyhole limpet haemocyanin-conjugated peptides 
in rabbits as follows: GQ92 (EKVSAFENPYVDAIKS; G,, 119-134) 
and GQ93B (CQLNLKEYNLV; G,, 350-359). Antibody GQ93B dis- 
played properties indistinguishable from CQ2 [39]. Other antibodies 
were from the following sources: Gp, and Goz (SW/l; New England 
Nuclear; Regensdorf, Switzerland) and PLCpl (Upstate Biotechnol- 
ogy, Lake Placid, NY). Antibodies against G,,, and GY, were kind gifts 
from Professor M.I. Simon (California Institute of Technology) and 
Dr. N. Gautam (Washington University), respectively. 
3. Results and discussion 
.S. porn& transformed with NK2/REPI and grown for 18 h 
under inducing conditions gave considerable displaceable bind- 
ing of the NK2 receptor-selective antagonist radioligand 
[jH]SR48968 in membrane fractions. No binding was detected 
in membranes derived from control cells (data not shown). 
Despite this, [‘H]SR48968 binding to intact cells expressing the 
Fig. 1. NK2 receptor [3H]SR48968 saturation binding and Scatchard 
analysis. Binding experiments were performed with S. pombe trans- 
formed with human NK2 receptor cDNA fused to a signal sequence 
derived from the yeast secreted phosphatase phol and subcloned into 
pREP1. Fission yeast were grown for 18 h in the absence of thiamine 
and intact cells (A) or membrane fractions (C) incubated with increas- 
ing concentrations of [‘H]SR48968 in the absence (Total) or presence 
(Non-specific) of 2 PM GR94800 (see section 2). Non-specific binding 
was subtracted from total to give specific binding which was saturable 
and gave linear Scatchard transformation for both intact cells (B) and 
membrane fractions (D). Data points are the mean of triplicate determi- 
nations and are representative of six independent experiments. 
NK2 receptor was indistinguishable from control cells (data 
not shown), suggesting inappropriate receptor trafficking and 
no translocation to the cell surface. To overcome this problem, 
the signal sequence derived from the endogenous yeast cell- 
surface phosphatase phol [40] was fused to the S-end of the 
cDNA encoding the human NK2 receptor. Expression of this 
construct resulted in a clear increase in [3H]SR48968 binding 
to intact cells which was both saturable and displaceable by the 
NK2 antagonist GR94800 (Fig. 1A). Scatchard transformation 
of this data was linear and gave a maximal binding capacity of 
429 ? 31.5 NK2 receptors/cell (n = 6) and a Kd = 0.52 ? 0.23 
nM (n = 6) (Fig. 1B). To test the proportion of the total NK2 
receptor population localized at the cell surface, parallel meas- 
urements were performed using crude homogenates containing 
total cell membranes. Binding to homogenates gave saturable 
binding (Fig. 1C) and linear Scatchard transformation (Fig. 
1D) indicated a K,, = 1.6 & 0.4 nM (n = 3) and a total binding 
capacity of 55 14 f 1599 (n = 3) NK2 receptors/cell. This corre- 
sponds to 1159 f 534 (n = 3) fmol NK2 receptor/mg of total 
cell protein. Together, these experiments indicate that 
5.0 + 3.2% (n = 3) of total cell NK2 receptor-binding activity 
is expressed at the cell surface. 
To examine the pharmacological characteristics of the 
human NK2 receptor expressed in S. pombe, both intact cells 
and crude homogenates were incubated with the non-peptide 
antagonist [‘H]SR48968 in the presence of increasing concen- 
trations of the natural agonist neurokinin A (NKA) or the 
NK2-selective antagonist GR94800 [37]. While GR94800 dis- 
played similar high affinity in both whole cells (IC,, = 5.5 ? 1.8 
nM (n = 6)) and membranes (18.1 f 3.7 nM (n = 4)), NKA 
showed a clear preference for binding to intact yeast cells where 
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‘ig. 2. Competition for NK2 receptor binding by NKA and GR94800. 
Competition binding was performed using S. pombe transformed with 
,uman NK2 cDNA fused to the signal sequence from yeast phol and 
ubcloned in pREPI. Fission yeast expressed either NK2 receptor alone 
4,B) or co-transformed with C,, subcloned in pREP4. Gflz in pREP7 
nd G,, in pREP5 (C,D). Yeast was grown for 18 h in the absence of 
hiamine and intact cells (A,C) or membrane fractions ((B,D) incubated 
Jith increasing concentrations of the natural agonist neurokinin A 
NKA) or antagonist GR94800 in the presence of 0.75 nM 
‘HlSR48968. Binding experiments performed as described in section 
Data points are the mean of triplicate determinations and are repre- 
entative of four to six independent experiments, 
ts ZC,, = 45.0 ?. 6.0 nM (n = 4) (Fig. 2A,B). NKA concentra- 
ions at least 100-fold higher were required to inhibit 
“HlSR48968binding crude cell homogenates (ZC,,, > 10 PM) 
Fig. 2B). This lower potency does not reflect hydrolytic break- 
lown of ligand as NKA preincubated with yeast homogenates 
mder normal assay conditions was unaltered in its ability to 
j lisplace [‘H]SR48968 binding from intact cells with high affin- 
ty (not shown). Identical differential binding to intact and 
rroken S. pombe cells was also observed with the NK2-selective 
tgonist GR64349 [41] (data not shown). One potential explana- 
ion for this observation is that the cell surface NK2 receptor 
s able to interact with an endogenous S. pombr heterotrimeric 
;-protein resulting in stabilization of a high-affinity agonist 
eceptor-binding state [42]. Currently, two endogenous G-pro- 
ein a-chains, termed gpal and gpa2, have been identified mol- 
,cularly in fission yeast [20,21] and both represent candidate 
,omponents for such an interaction. However, while this is not 
,xcluded, receptor theory [42] predicts that normal levels of 
:uanine nucleotide within yeast cytosol should disrupt recep- 
or-G-protein ternary complex and with it abolish high-affinity 
agonist binding in intact cells. An alternative possibility is that 
,ompetition for [‘H]SR48968 binding by NKA in intact yeast 
.ells is unrelated to a high-affinity NK2 receptor conformation 
IS induced through G-protein interaction. Indeed, in Chinese 
tamster, ovary cells expressing the recombinant rat NK2 recep- 
or, high-affinity agonist binding reflecting interaction with en- 
logenous G-proteins is observed only when using radiolabeled 
\JKA as ligand [43]. It seems that demonstration of guanine 
urcleotide-sensitive high-affinity displacement of [‘H]SR48968 
>inding by NKA may only be observed clearly in mammalian 
:ells upon over expression of appropriate G-protein compo- 
tents, such as G,, (see below; Fig. 4A). Rather than reflecting 
G-protein interaction, high-affinity NKA binding in intact 
yeast may, therefore, indicate that the fraction of NK2 recep- 
tors inserted within the plasma membrane undergo a posttrans- 
lational modification (e.g. glycosylation, phosphorylation or 
palmitoylation) distinct from that experienced by receptors lo- 
calized in other membrane compartments. Selective cleavage of 
the phol signal sequence in cell surface receptors does not 
account for this observation as wild-type NK2 receptor binding 
in membranes displays equally low-affinity NKA binding (data 
not shown). 
To test whether the human NK2 receptor expressed in S. 
pombr was able to interact functionally with its natural G- 
protein G,, mammalian Gaq, GB, or G,, and G,, subunits were 
co-expressed following subcloning into the vectors REP4, 
REP7 and REPS, respectively. G,, has been reported previ- 
ously to effectively form dimers with both Gfi, and G,? [44,45]. 
Following growth in the absence of thiamine, all G-protein 
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Fig. 3. Immunodetection of G,,, Go,. GBz, G,, and PLCal expressed 
in S. pombe. Fission yeast co-transformed with NKZlphoZ subcloned 
in pREP1 together with G,, in pREP4, G,, in pREP5 and either Gfi, 
or Ggz in pREP7 were used for immunodetection of G-protein compo- 
nents. Yeast transformed only with PLC/?l expressed from pREP3 was 
also used for Western analysis. Cells were grown for 18 h in the absence 
of thiamine after which time homogenates were prepared by cell break- 
age using glass beads. Proteins were separated by SDS-PAGE, trans- 
ferred to nitrocellulose paper and probed with antibodies specific for 
G,, (A), G,, or G,, (B), G,, (C) and PLCB, (D). Antibody binding was 
detected using HRP-conjugated second antibody or protein A/G to- 
gether with ECL detection. Molecular weight markers and the position 
of immunodetected protein are indicated in each panel. Untransformed 
S. pombe and a rat brain crude homogenate were used as negative and 
positive controls, respectively. 
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Fig. 4. Agonist binding to NK2 receptor is regulated by G,, in COS 
cells but not S. pombe. (A) COS-7 cells expressing human NK2 receptor 
alone or together with G,, were used to prepare membranes and 
[‘H]SR48968 binding measured in the presence of increasing concentra- 
tions of NKA. Compared with cells expressing NK2 receptor alone, 
radioligand binding was inhibited by lower concentrations of NKA 
upon co-expression with G,, and this increased agonist affinity was 
abolished by co-incubation in the presence of 100 ,uM GTPyS. 
(B) Membrane fractions prepared from S. pombe co-expressing NK2/ 
phol together with immunodetectable G,,, Gs2 and G,, were incubated 
with [‘H]SR48968 in the presence of NKA or GR94800 as indicated. 
Neither agonist- nor antagonist-binding profiles were altered upon co- 
incubation with 100 PM GTPJS. Data points are the mean of triplicate 
determinations and representative of three to six independent experi- 
ments. 
components were immunodetectable in crude yeast homoge- 
nates migrating at 42 kDa (G,,; Fig. 3A), 35 kDa (GB, and GB2; 
Fig. 3B) or 8 kDa (G,,; Fig. 3C). These sizes are identical with 
those identified previously in native tissues and following ex- 
pression in mammalian cells [2]. All G-protein components 
were localized predominantly in membrane fractions and solu- 
ble in the presence of 1% cholate (data not shown). When the 
NK2 receptor is co-expressed with G,, in COS cells, guanine 
nucleotide-sensitive high-affinity agonist binding is increased 
considerably (Fig. 4A). Despite this, NK2 receptor expressed 
together with Garq, GB2 and G,, in S. pombe displayed essentially 
identical pharmacological characteristics as NK2 receptor ex- 
pressed alone. Hence, the antagonist GR94800 inhibited 
[3H]SR48968 binding potently in both intact cells and crude 
homogenates while NKA bound with high affinity only in un- 
broken cells (Fig. 2C,D). Neither antagonist or agonist binding 
to membranes was altered in the presence of 100 FM GTPyS 
(Fig. 4B) even though in parallel experiments GTPyS abolished 
totally G,,-dependent high-affinity NKA binding in COS cells 
(Fig. 4A). 
One potential explanation for the absence of guanine nucle- 
otide-sensitive high-affinity agonist binding to yeast mem- 
branes expressing NK2 receptor co-expressed with Gaq, GB, 
and G,, is misfolding, inactivation or inappropriate modifica- 
tion of mammalian G-protein components. As an additonal test 
of function for G, from S. pombe, we established a system to 
assess G,-dependent PLC/I activation as reported for purified 
mammalian components [46,47]. Bovine PLC/31 [34] was sub- 
cloned into the REP1 and expressed in S. pombe. Following 
growth in the absence of thiamine, PLCjU was immunodetecta- 
ble as a 150-kDa protein localized exclusively in membrane 
fractions (Fig. 3D). Consistent with expression of PLCBl, yeast 
extracts hydrolysed exogenously supplied [3H]PIP, and this ac- 
tivity was stimulated considerably by free Ca2’ at 10m5M (Fig. 
5A). Control membranes were inactive (data not shown). As 
reported recently [48], G,, expressed recombinantly in bacu- 
lovirus-infected SI9 insect cells stimulates PLCPI activity fol- 
S. Arkinstall et al. IFEBS Letters 375 (1995) 183-187 
lowing preactivation by GTPyS while GDP@ was totally inac- 
tive (Fig. SB). In contrast, G,, expressed in S. pombe was 
unable to mediate activation of PLCjIl at any concentration of 
free Ca” between lo-’ to 10m5M (Fig. 5C). G,,, is an additional 
member of the G, family of G-protein a-chains which is 56% 
identical in amino acid sequence to G,, [5,49] and also mediates 
powerful activation of PLCji isoenzymes [9,50]. Human G,,, 
was expressed in both S. pombe and COS cells where it was 
immunodetectable as a protein migrating at 43 kDa (data not 
shown). While membranes from COS cells expressing G,,, me- 
diate powerful GTPyS-stimulated PLCal activation (Fig. 5D), 
preparations from S. pombe expressing G,,, were indistinguish- 
able from control membranes (Fig. 5D). Together, these obser- 
vations indicate that, although both G,, and Gal6 are expressed 
in S. pombe at high levels with the expected molecular weight, 
they are inactive and unable to activate their downstream eflec- 
tor target PLC/?l in response to GTPyS. 
In summary, this is the first report of a mammalian seven- 
transmembrane receptor heterologously co-expressed with G- 
protein subunits in the fission yeast S. pombe. The NK2 recep- 
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Fig. 5. Recombinant PLC/?l produced in S. pombe is activated by G,, 
and G,,, from baculovirus-infected Sl9 cells and COS cells but not from 
fission yeast. S. pombe transformed with PLCgl subcloned in pREP3 
was grown for 18 h in the absence of thiamine after which time homo- 
genates were prepared by cell breakage with glass beads. (A) Ca”- 
stimulated hydrolysis of exogenous [3H]PIP, by PLC/Il expressed in 
crude homogenates of transformed fission yeast. Control cells gave 
undetectable phospholipid hydrolysis. (B) PLCgl is stimulated by G,, 
produced in baculovirus-infected Sl9 cells preactivated in the presence 
of increasing concentrations of GTPyS. GDPbS preincubation did not 
activate G,,. Free Ca*’ concentrations were maintained at lo-‘M. 
(C) G,, generated by baculovirus-infected Sf9 cells and preactivated by 
100 ,uM GTPyS stimulates PLC/31 at all free Ca*’ concentrations be- 
tween lo-‘M and 10m5M. G,, expressed in S. pombe is totally inactive 
under identical conditions. Data points are the mean of triplicate deter- 
minations and representative of three independent experiments. (D) 
Membranes prepared from COS cells and S. pombe expressing either 
G,, or G,,, were incubated with PLCgl in the presence of GTPyS (100 
,uM) and [‘HIPIP,. Only G-proteins overexpressed in COS cell mem- 
branes mediated PLCgl activation. Bars represent fold stimulation 
over basal activity by GTPyS and are the mean of triplicate determina- 
tions. 
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t ,3r displays expected pharmacological characteristics and a 
proportion of these receptors can be expressed at the cell sur- 
1 Ltce. The G-protein subunits Golq, GB,, Ggz and G,, were mem- 
brane associated and exhibited expected molecular weights. We 
also report the first expression in yeast of functional PLCpl. 
\Vhile both receptor and effector molecules produced in S. 
1 ombe are biologically active, receptor-linked G-protein cou- 
1 ling breaks down at least in part because G,, is inactive. 
! imilar observations with Gz,6 indicate functional inactivity for 
s ther members of the G, family of G-proteins generated in 
‘. pombe. 
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